ADVFN US – Market Content Editor
-

Wendy’s Stock Hits 52-Week Low Amid Industry Headwinds and Leadership Changes
Wendy’s Co. (NASDAQ:WEN) shares fell to a 52-week low of $10.93, down more than 30% from last year’s high of $20.60, marking a steep decline for the fast-food chain. This drop reflects both sector-wide pressures and company-specific challenges. Despite the stock’s slump, Wendy’s fundamentals remain solid, with a price-to-earnings ratio of 11.7 and a dividend…
-

BiomX Shares Surge 60% Following Start of Phase 2b Trial for Cystic Fibrosis Treatment
BiomX Inc. (AMEX:PHGE) saw its stock jump 60% after announcing the commencement of patient dosing in its Phase 2b clinical trial evaluating BX004 for cystic fibrosis patients suffering from chronic Pseudomonas aeruginosa infections. This randomized, double-blind, placebo-controlled study will enroll around 60 cystic fibrosis patients, who will receive either BX004 or a placebo via inhalation…
-

SEALSQ Shares Decline Following $60 Million Equity Offering Announcement
SEALSQ Corp (NASDAQ:LAES) saw its stock drop 7.2% after revealing plans for a $60 million equity raise that could lead to notable dilution for current shareholders. The company, specializing in semiconductors and post-quantum technology, disclosed it has signed a securities purchase agreement with institutional investors to sell 15 million ordinary shares bundled with warrants to…
-

Eco Wave Power Shares Climb Following Completion of Floaters for Los Angeles Project
Eco Wave Power Global AB (NASDAQ:WAVE) saw its stock rise by 3% after the company announced it has finished manufacturing all floaters for its inaugural wave energy project in the U.S., located at the Port of Los Angeles. This milestone is a key step forward as Eco Wave Power gears up to launch the nation’s…
-

Unusual Machines Shares Drop Sharply Following $48.5 Million Discounted Offering
Unusual Machines, Inc. (AMEX:UMAC) saw its stock price tumble 18% on Monday after announcing a registered direct offering valued at $48.5 million, priced well below its recent market closing value. The deal involves selling 5 million common shares (or pre-funded warrants) at $9.70 each, a notable discount compared to Friday’s closing price of $12.12. This…
-

Rani Therapeutics Shares Surge After ENDO 2025 Presentation Announcement
Rani Therapeutics Holdings Inc (NASDAQ:RANI) experienced an 18% jump in its stock price following news that the clinical-stage biotherapeutics company will present preclinical findings on its innovative RaniPill capsule at the upcoming Endocrine Society Annual Meeting (ENDO 2025) in July 2025. The presentation will highlight data showcasing the bioequivalence between an oral bispecific GLP-1/GLP-2 receptor…
-

Upstart Shares Drop Following Goldman Sachs Initiation with Sell Rating
Upstart Holdings Inc (NASDAQ:UPST) saw its stock decline by 6% in pre-market trading Monday after Goldman Sachs analyst Will Nance initiated coverage on the company, assigning a Sell rating and setting a price target of $71. This target suggests a potential 10% drop from the stock’s closing price of $75.62 on Friday. Nance’s Sell rating…
-

Bitmine Immersion Technologies Rises as Ethereum Holdings Cross $500M Mark
Shares of Bitmine Immersion Technologies Inc (AMEX:BMNR) rose 5.4% after the company announced that its Ethereum holdings have surpassed half a billion dollars in value. As of July 14 at 7:45 a.m. ET, Bitmine reported owning 163,142 ETH, valued at roughly $501 million, based on an ETH price of $3,072.67. The update follows closely on…
-

Firefly Neuroscience Shares Tick Higher on Heidelberg University Research Collaboration
Shares of Firefly Neuroscience Inc (NASDAQ:AIFF) climbed 3% after the company highlighted its collaboration with Heidelberg University Hospital on a research project exploring the neurological effects of 15q13.3 copy number variants (CNVs). The partnership involves analyzing EEG data from 30 individuals using Firefly’s FDA-cleared brain health assessment platform. Spearheaded by Prof. Dr. med. Christian Schaaf,…
-

Avalon GloboCare Shares Rise After Gaining New Patent for CAR-T Cell Technology in Hong Kong
Avalon GloboCare Corp (NASDAQ:ALBT) saw its stock jump 16% following the announcement that it has been granted a standard patent in Hong Kong for its proprietary CAR-T and CAR-Natural Killer (CAR-NK) cell technology. The newly issued Certificate of Invention—Patent No. HK40074322—was awarded by the Hong Kong Intellectual Property Department and is based on a previously…